T-REX 2X Long DJT Daily Target ETF (DJTU)
Live price chart, market sentiment, and community perspectives for T-REX 2X Long DJT Daily Target ETF (CBOE: DJTU).
Live price chart, market sentiment, and community perspectives for T-REX 2X Long DJT Daily Target ETF (CBOE: DJTU).
On our trading desk, watching the technical setup for DJTU has been nothing short of a masterclass in leveraged decay. With the technical outlook flashing a definitive 'Strong Sell' alongside a bearish Death Cross on long-term moving averages, anyone treating this as a buy-and-hold vehicle is ignoring basic math. The fund's price action—collapsing from its May 2025 highs down to single digits and forcing a 1-for-10 reverse split last July—shows how violently daily-reset target ETFs punish you when the underlying asset trends downward or experiences choppy intraday trading. We strictly advise treating this strictly as an intraday tactical instrument rather than a political statement or long-term investment.
From a quantitative risk perspective, DJTU's metrics are flashing every warning sign in the book. A 1-year beta of 3.27 and a 2-year beta of 3.18 mean you are taking on roughly triple the volatility of a standard benchmark, but with none of the structural stability. When you combine that kind of amplified exposure with deeply negative Sharpe and Sortino ratios of -0.89 and -1.45 respectively, the risk-adjusted return profile breaks down completely. Even though short interest dropped significantly to under 1% by late July, that doesn't mitigate the structural decay baked into a 2X daily-reset product targeting a stock as volatile as DJT.
When evaluating candidates or junior analysts on their understanding of single-stock leveraged ETFs, I always point them to case studies like the T-REX 2X Long DJT Daily Target ETF. You have to understand that the fund's objective is strictly limited to a single trading day—seeking 200% of DJT's daily performance—meaning holding it past the closing bell exposes you to compounding errors and path dependency. Looking at the recent data showing a 50-day moving average around $12.23 and a 200-day moving average near $17.13, candidates need to explain how volatility drag eats away at principal over time, especially when an asset undergoes massive drawdowns from its $28.39 all-time high set back in May 2025.
Explore plasma cleansing, somatic organ swaps, and BCI.